- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/06 - Dipeptides
Détention brevets de la classe C07K 5/06
Brevets de cette classe: 796
Historique des publications depuis 10 ans
|
45
|
35
|
43
|
73
|
76
|
67
|
58
|
40
|
19
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| MedImmune Limited | 616 |
13 |
| Ajinomoto Co., Inc. | 2304 |
12 |
| Ramot at Tel-Aviv University Ltd. | 1474 |
11 |
| Novartis AG | 10847 |
10 |
| Cornell University | 3302 |
8 |
| Suntory Holdings Limited | 2029 |
8 |
| Bristol-myers Squibb Company | 4878 |
7 |
| Takeda Pharmaceutical Company Limited | 2714 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2567 |
7 |
| NeoStrata Company, Inc. | 10 |
7 |
| Servier Pharmaceuticals, LLC | 104 |
7 |
| F. Hoffmann-La Roche AG | 7930 |
6 |
| The Regents of the University of California | 19898 |
6 |
| Medivir AB | 131 |
6 |
| Onyx Therapeutics, Inc. | 68 |
6 |
| The Scripps Research Institute | 1346 |
6 |
| Tokyo Institute of Technology | 1373 |
6 |
| Centre National de La Recherche Scientifique | 10421 |
5 |
| Achillion Pharmaceuticals, Inc. | 165 |
5 |
| Apotex Technologies Inc. | 16 |
5 |
| Autres propriétaires | 648 |